Handel nachbörslich: 1.35

Tempest Therapeutics Inc (TPST)

Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten

Tempest Therapeutics Inc (TPST)

Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Keeping an Eye on Tempest Therapeutics Inc (TPST) After Insider Trading Activity - Knox Daily

Tempest Further Strengthens Leadership Team with - GlobeNewswire

Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs - StockTitan

Tempest Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

An Analysis of Tempest Therapeutics Inc (TPST)’s Potential Price Growth - Knox Daily

Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Tempest Therapeutics Inc [TPST] Records 200-Day SMA of $3.1810 - Knox Daily

Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance

Is Tempest Therapeutics Inc (TPST) worth investing in despite its undervalued state? - US Post News

Scotiabank initates Tempest Therapeutics Inc (TPST) stock to a Sector outperform - Knox Daily

Anchoring Your Portfolio: Is TPST Stock a Safe Harbor? - The InvestChronicle

Ratios Uncovered: Breaking Down Tempest Therapeutics Inc (TPST)’s Trailing Twelve Months Metrics - The Dwinnex

You might want to take a look at Tempest Therapeutics Inc (TPST) now - SETE News

The Attractiveness of Investing In Tempest Therapeutics Inc (TPST) is Growing - Knox Daily

Investor’s Toolkit: Key Ratios for Assessing Tempest Therapeutics Inc (TPST)’s Performance - The Dwinnex

How To Buy Tempest Therapeutics Inc. Stock Online in August 2024 - Traders Union

Should investors be concerned about Tempest Therapeutics Inc (TPST)? - US Post News

TPST’s 2023 Market Dance: Down -67.73% – Time to Invest? - The InvestChronicle

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Tempest Therapeutics Inc [TPST] Owner makes an insider purchase of 387,999 shares worth 0.43 million. - Knox Daily

Tempest Therapeutics appoints new VP of Quality Assurance - Investing.com

Check out these key findings about Tempest Therapeutics Inc (TPST) - SETE News

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance - GlobeNewswire

Market Momentum Report: Tempest Therapeutics Inc (TPST)’s Positive Close at 1.46 - The Dwinnex

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance - StockTitan

Tempest Therapeutics Inc [TPST] Investment Guide: What You Need to Know - Knoxdaily.com

How should investors view Tempest Therapeutics Inc (TPST)? - US Post News

Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday? - MSN

Tempest Therapeutics (NASDAQ:TPST) Stock Rating Reaffirmed by HC Wainwright - Defense World

Tempest Therapeutics Inc [TPST] Shares Rise 30.25% on Thursday - Knox Daily

TPST’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Scotiabank maintains a target on Tempest Therapeutics stock By Investing.com - Investing.com Canada

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial By Investing.com - Investing.com Canada

Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday? - Benzinga

Tempest stock jumps on positive FDA feedback (NASDAQ:TPST) - Seeking Alpha

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial - Investing.com

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial By Investing.com - Investing.com Australia

Tempest Therapeutics Inc (TPST) Is Worth Accumulating At Current Levels - Stocks Register

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial By Investing.com - Investing.com India

Tempest Therapeutics aligns with FDA on Phase 3 cancer trial By Investing.com - Investing.com UK

Tempest Announces Successful End-of-Phase 2 Meeting with - GlobeNewswire

Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma - StockTitan

Its Stock Has Paid Off Big Time For Tempest Therapeutics Inc - SETE News

Scotiabank slashes price target on Tempest Therapeutics Inc [TPST] – find out why. - The DBT News

Tempest Flounders on News of Test Results - MSN

Tempest Therapeutics, Inc. (NASDAQ:TPST) Major Shareholder Versant Venture Capital Vi, L. Sells 400,000 Shares of Stock - Defense World

Tempest Therapeutics, Inc. (NASDAQ:TPST) Major Shareholder Versant Venture Capital Vi, L. Sells 387,999 Shares - Defense World

Versant entities sell Tempest Therapeutics shares worth over $967k - Investing.com

Tempest Therapeutics Inc Inc. (TPST) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Financial Health Report: Tempest Therapeutics Inc (TPST)’s Ratios Tell a Tale - The Dwinnex

Was anything negative for Tempest Therapeutics Inc (TPST) stock last session? - US Post News

TPST Stock Earnings: Tempest Therapeutics Misses EPS for Q2 2024 - MSN

TPST Stock Earnings: Tempest Therapeutics Misses EPS for Q2 2024 - InvestorPlace

A company insider recently bought 35,000 shares of Tempest Therapeutics Inc [TPST]. Should You Buy? - Knox Daily

TPSTTempest Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update - ForexTV.com

Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update - wallstreet:online

Virtu Financial LLC Acquires 11,689 Shares of Tempest Therapeutics, Inc. (NASDAQ:TPST) - Defense World

A closer look at Tempest Therapeutics Inc (TPST)’s stock price trends - US Post News

TPST Stock Update: Tempest Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Ähnlich wie TPST